Literature DB >> 25499401

Severe hyponatremia associated with thiazide diuretic use.

Gurkiran K Sardar1, Wesley P Eilbert1.   

Abstract

BACKGROUND: Thiazide diuretics are commonly used as first-line antihypertensive agents. Hyponatremia is a reported, though uncommon, complication of thiazide use. Although the exact mechanism of thiazide-induced hyponatremia (TIH) is unclear, it can be a significant cause of morbidity and mortality. CASE REPORT: We report a 69-year-old man with generalized weakness beginning 2 weeks after starting hydrochlorothiazide (HCTZ). Evaluation revealed a serum sodium level of 120 mmol/L. The patient was admitted and successfully treated with free water restriction and discontinuation of the HCTZ. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Hyponatremia is an uncommon complication of thiazide diuretic use, which frequently presents with nonspecific symptoms. Identification of TIH is crucial to prevent its potentially life-threatening complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diuretics; hyponatremia; hyponatremia management; thiazide-induced hyponatremia; thiazides

Mesh:

Substances:

Year:  2014        PMID: 25499401     DOI: 10.1016/j.jemermed.2014.09.054

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  Thiazide-associated hyponatremia in the elderly: what the clinician needs to know.

Authors:  George Liamis; Theodosios D Filippatos; Moses S Elisaf
Journal:  J Geriatr Cardiol       Date:  2016-02       Impact factor: 3.327

2.  The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange.

Authors:  Saeko Kumon; Ryosuke Usui; Shinzo Kuzuhara; Kosaku Nitta; Minako Koike
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

Review 3.  Hyponatremia in the elderly: challenges and solutions.

Authors:  Theodosios D Filippatos; Andromachi Makri; Moses S Elisaf; George Liamis
Journal:  Clin Interv Aging       Date:  2017-11-14       Impact factor: 4.458

4.  Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics.

Authors:  Biff F Palmer; Amy D Rock; Emily J Woodward
Journal:  Drug Des Devel Ther       Date:  2016-01-18       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.